Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Unilever's $68 Billion Health Kick is the Wrong Remedy

Wall Street Journal - 17 Jan 2022 16:38
A surprise bid for the consumer-healthcare business jointly owned by GlaxoSmithKline and Pfizer is risky and only half of the target may really be worth owning.
Full Article at Wall Street Journal

More Market News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard